Expanded Access TAK-881-3002 PIDD

Study Details

Full Title

Expanded Access Program for United States of America: For the Treatment of Primary Immunodeficiency Diseases (PIDD) with TAK-881 Subcutaneous

Principal Investigator

Niraj
Patel

Protocol Number

PRO00118862

Phase

N/A

Enrollment Status

Open to Enrollment